Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Mycopathologia ; 189(1): 2, 2024 Jan 13.
Article in English | MEDLINE | ID: mdl-38217794

ABSTRACT

Trichophyton species cause dermatophytosis in humans, with a high, worldwide frequency of reports and important public health relevance. We evaluated 61 Trichophyton strains from different sources deposited in the University Recife Mycology (URM) culture collection of the Universidade Federal de Pernambuco, Brazil. Strains were phenotypically identified and confirmed by sequencing Internal Transcribed Spacers rDNA and partial beta-tubulin 2-exon. Additionally, we evaluated their susceptibility to terbinafine and itraconazole. Physiological analyses included urease activity and growth in casein medium. Phenotypic methods allowed the reliable identification of T. rubrum only, whereas, for other species, molecular methods were mandatory. All Trichophyton species exhibited susceptibility profiles to itraconazole (0.04-5.33 µg/mL) and terbinafine (0.17-3.33 µg/mL). Our analyses revealed a heterogeneous distribution of T. mentagrophytes, which does not support the current distribution within the species complex of T. mentagrophytes and its genotypes.


Subject(s)
Arthrodermataceae , Tinea , Humans , Trichophyton , Terbinafine/pharmacology , Antifungal Agents/pharmacology , Itraconazole , Brazil , Universities , Microbial Sensitivity Tests , Arthrodermataceae/genetics
2.
Future Microbiol ; 18: 1225-1233, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37882752

ABSTRACT

Aim: To evaluate antifungal potential of 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hybrids based on thiosemicarbazones and thiazolidinediones against pathogenic Sporothrix species. Methods: Antifungal activity of nine compounds were assessed by broth microdilution. Interactions between active compounds and itraconazole were evaluated by the checkerboard assay using non-wild-type isolates. Cytotoxicity of the compounds was determined. Results: Four C-3 substituted analogs showed antifungal activity, unrelated to thiosemicarbazone or thiazolidinedione functions. Synergistic interactions between the four compounds and itraconazole, and low toxicity on mouse fibroblast cells were observed. Activity of 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hybrids against Sporothrix depended on the substitution on the imidazopyrazine ring. Conclusion: Antifungal potential, overcoming itraconazole resistance and low toxicity indicate the possible use of that series of compounds in a therapeutic alternative for treatment of sporotrichosis.


Subject(s)
Sporothrix , Thiazolidinediones , Thiosemicarbazones , Animals , Mice , Antifungal Agents/pharmacology , Itraconazole/pharmacology , Thiosemicarbazones/pharmacology , Microbial Sensitivity Tests
3.
Future Microbiol ; 17: 903-915, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35748170

ABSTRACT

Candida nivariensis caused refractory esophagitis in a 36-year-old Brazilian man coinfected with HIV and Leishmania. A literature review on this rare fungal pathogen is also presented. The diagnosis was made, and pathogen identification was performed using matrix-assisted laser desorption ionization-time of flight mass spectrometry and sequencing of the LSU/26S region. An antifungigram was performed using broth microdilution. A literature search of PubMed was performed. The causative agent, C. nivariensis, was resistant to fluconazole and voriconazole. The patient's condition worsened considerably, and he passed away. This is the second report of this Candida species in Brazil and the first case reported worldwide of refractory esophagitis in a patient coinfected with HIV and Leishmania. The case illustrates the importance of precise identification and antifungal susceptibility testing when isolating this emerging pathogen.


Subject(s)
Esophagitis , HIV Infections , Adult , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Brazil , Drug Resistance, Fungal , Esophagitis/diagnosis , Esophagitis/drug therapy , Fluconazole/pharmacology , Fluconazole/therapeutic use , HIV Infections/drug therapy , Humans , Male , Microbial Sensitivity Tests , Saccharomyces cerevisiae , Saccharomycetales
4.
J Mycol Med ; 32(1): 101213, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34758424

ABSTRACT

Mycobacterium tuberculosis, which is responsible for tuberculosis (TB) and Cryptococcus sp. responsible for cryptococcosis, are pathogenic microorganisms that especially affect patients infected with the human immunodeficiency virus (HIV). Both diseases present similar classic symptoms, which makes diagnosis and treatment consequently difficult. To our knowledge, a few reported cases of M. tuberculosis and Cryptococcus sp. co-infection in non-HIV patients exist. This study reports a TB and neurocryptococcosis (NC) comorbidity case in a patient who had no clinical or serological evidence of HIV-compromised immunity. A 49-year-old male patient, a farmer with a low education level, previously diagnosed with TB and was undergoing treatment for a month when he presented progressive headaches, fever, drowsiness and photosensitivity, a stiff neck and a positive Lasègue test. During hospitalization, the patient was also diagnosed with NC through cerebrospinal fluid (CSF) analysis, which revealed the presence of capsulated yeasts by contrast with india ink. Following the yeast isolation, proteomic and molecular analyzes were performed. The patient received antifungal therapy in parallel with TB treatment, which caused complications and had to be modified twice. However, after three months of hospitalization the patient was discharged. Tuberculosis and cryptococcosis co-infection is a clinical and laboratory challenge, often leading to a delay in diagnosis. In this paper we emphasize the need to understand these infectious comorbidities in non-HIV patients from South America, since the few cases reported in the literature are from studies conducted in the United States and China.


Subject(s)
Cryptococcosis , Cryptococcus neoformans , HIV Infections , Tuberculosis , Comorbidity , Cryptococcosis/diagnosis , Cryptococcosis/drug therapy , Cryptococcosis/epidemiology , Cryptococcus neoformans/genetics , HIV Infections/microbiology , Humans , Male , Middle Aged , Proteomics , Tuberculosis/complications
5.
Future Microbiol ; 16: 1371-1379, 2021 12.
Article in English | MEDLINE | ID: mdl-34812048

ABSTRACT

Aim: Cases of sporotrichosis are emerging in several states of Brazil, especially in the southeast. Recently, sporotrichosis has been reported in the state of Pernambuco in the northeastern region. The goal of this study was to shed new light on sporotrichosis in terms of the geographic distribution of human cases and provide an overview of sporotrichosis associated with zoonotic transmission. Patients & methods: From March 2017 to November 2019, 179 patients were diagnosed with sporotrichosis. Georeferencing analysis, spatial distribution and epidemiological features of all cases are described. Results: The data show the dynamics of accelerated transmission of sporotrichosis across urban and coastal areas of the state of Pernambuco. Conclusion: There is a need to decentralize health services and implement a One Health approach to this emerging disease.


Subject(s)
Sporothrix , Sporotrichosis , Brazil/epidemiology , Humans , Sporotrichosis/epidemiology
7.
PLoS Negl Trop Dis ; 14(3): e0008151, 2020 03.
Article in English | MEDLINE | ID: mdl-32226021

ABSTRACT

Sporothrix chilensis is a mild-pathogenical specie of Sporothrix pallida complex, until now, known as restrict to Chile. Herein, we describe the first clinical isolates identified as S. chilensis in Brazil, preserved in the URM Culture Collection, by polyphasic taxonomy, and their respective antifungal profile of this emergent fungus.


Subject(s)
Sporothrix/classification , Sporothrix/isolation & purification , Sporotrichosis/microbiology , Antifungal Agents/pharmacology , Brazil , Humans , Microbial Sensitivity Tests , Mycological Typing Techniques , Sequence Analysis, DNA , Sporothrix/genetics , Sporothrix/physiology , Tubulin/genetics
9.
Proc Natl Acad Sci U S A ; 112(44): 13639-44, 2015 11 03.
Article in English | MEDLINE | ID: mdl-26483491

ABSTRACT

Dogs were the first domesticated species, originating at least 15,000 y ago from Eurasian gray wolves. Dogs today consist primarily of two specialized groups--a diverse set of nearly 400 pure breeds and a far more populous group of free-ranging animals adapted to a human commensal lifestyle (village dogs). Village dogs are more genetically diverse and geographically widespread than purebred dogs making them vital for unraveling dog population history. Using a semicustom 185,805-marker genotyping array, we conducted a large-scale survey of autosomal, mitochondrial, and Y chromosome diversity in 4,676 purebred dogs from 161 breeds and 549 village dogs from 38 countries. Geographic structure shows both isolation and gene flow have shaped genetic diversity in village dog populations. Some populations (notably those in the Neotropics and the South Pacific) are almost completely derived from European stock, whereas others are clearly admixed between indigenous and European dogs. Importantly, many populations--including those of Vietnam, India, and Egypt-show minimal evidence of European admixture. These populations exhibit a clear gradient of short--range linkage disequilibrium consistent with a Central Asian domestication origin.


Subject(s)
Dogs/genetics , Genetics, Population , Animals , Animals, Domestic , Asia
SELECTION OF CITATIONS
SEARCH DETAIL
...